The pharmaceutical industry is a multi-billion dollar a year business, and although Americans make up only 5% of the world’s population, we consume 44% of all prescription medications manufactured and distributed worldwide. While some may debate the cause of this staggeringly disproportionate use of pharmaceutical products within the United States, undoubtedly the single most influential factor is that the United States allows drug manufacturers to market their products directly to consumers. This strategy, commonly referred as direct-to-consumer (DTC) advertising, results in $4 in pharmaceutical sales for every $1 spent on advertising. Recognizing the inherent risks of allowing such practices, DTC advertising has been outlawed in all but two countries, the United States and New Zealand (as of 2006, New Zealand’s government was considering legislation that would ban DTC). Thus, it is not surprising that millions of Americans go to their doctors requesting prescription medication, turning the traditional doctor-patient relationship on its head.
The combination of pharmaceutical companies and medical device manufacturers downplaying the side effects of their products or finding ways to skirt federal laws designed to provide consumer safety, and their flooding the airwaves with commercials touting their “magic pills” and products, can be a lethal and costly combination. Every year, thousands of Americans die or suffer adverse effects from prescription and over-the-counter drugs, and faulty medical devices. The FDA estimated that as many as 55,000 deaths were caused by Vioxx, alone, a popular arthritis medication that generated billions of dollars in revenue for its manufacturer. When this occurs, Kopelman Sitton Law Group fights for consumers, letting drug and device manufacturers know that placing profits above consumer safety will not be tolerated. We are recognized as a leader in the pursuit of legal claims against the powerful pharmaceutical industry, and have represented thousands of consumers who have suffered serious bodily injuries after ingesting defective medications of whose unreasonably dangerous side-effects the manufacturers did not warn. Kopelman Sitton Law Group predominantly has been retained to represent clients throughout the southeastern United States, but also has filed lawsuits on behalf of its clients in both state and federal courts in many states across the country.
Our pharmaceutical litigation practice includes our involvement in multi-district litigation, providing case development and trial support to various litigation consortiums dedicated to working to bring pharmaceutical manufacturers to task for injuries that result from the negligent manufacture or labeling of their products. Over the years, we have handled litigation involving a variety of pharmaceutical and medical device products including Fosamax, Actos, Vioxx, Celebrex, Re-Nu Contact Lens Solution, Fen-Phen, Rezulin, Baycol, PPA, Ortho Evra birth control patches, , Tequin, Trasylol, Propulsid, DePuy hips, Smith & Nephew hips, and Guidant Pacemakers/Defibrillators.